Literature DB >> 20110549

Carbon dioxide chemoreception and hypoventilation syndromes with autonomic dysregulation.

Michael S Carroll1, Pallavi P Patwari, Debra E Weese-Mayer.   

Abstract

Respiratory and autonomic disorders of infancy, childhood, and adulthood are a group of disorders that have varying presentation, combined with a range of severity of respiratory control and autonomic nervous system dysfunction. Within this group, congenital central hypoventilation syndrome and rapid onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation, exhibit the greatest respiratory control deficits, requiring supported ventilation as a mainstay of care. The discovery of the key role of the paired-like homeobox 2B gene in autonomic nervous system development, along with the identification of paired-like homeobox 2B gene mutations causing congenital central hypoventilation syndrome, has led to a fruitful dialog between basic scientists and physician-scientists, producing an explosion of knowledge regarding genotype-phenotype correlations in this disorder, as well as important animal models of chemosensory regulation deficit. Though the etiology of rapid onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation is still to be determined, recent studies have begun to carefully delineate the phenotype, suggesting that it too may provide fertile ground for research that both advances our knowledge and improves patient care.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110549     DOI: 10.1152/japplphysiol.00004.2010

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Obesity hypoventilation syndrome: A different beast.

Authors:  Ralph Folman; Danielle Grenier; Catherine Birken; Paolo Campisi; Minh T Do; Vito Forte; Ian Maclusky; Brian W McCrindle; Indra Narang; Manisha Witmans
Journal:  Paediatr Child Health       Date:  2013-01       Impact factor: 2.253

2.  Commentary: Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): Remember Your ABCs (Airway, Breathing, Circulation).

Authors:  Debra E Weese-Mayer; Casey M Rand; Diego Ize-Ludlow
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

Review 3.  Central respiratory chemoreception.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Douglas A Bayliss
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

Review 4.  Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation.

Authors:  Pallavi P Patwari; Michael S Carroll; Casey M Rand; Rajesh Kumar; Ronald Harper; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2010-06-30       Impact factor: 1.931

5.  Central CO2 chemoreception in cardiorespiratory control.

Authors:  Jay B Dean; Eugene E Nattie
Journal:  J Appl Physiol (1985)       Date:  2010-02-11

6.  TASK-2 channels contribute to pH sensitivity of retrotrapezoid nucleus chemoreceptor neurons.

Authors:  Sheng Wang; Najate Benamer; Sébastien Zanella; Natasha N Kumar; Yingtang Shi; Michelle Bévengut; David Penton; Patrice G Guyenet; Florian Lesage; Christian Gestreau; Jacques Barhanin; Douglas A Bayliss
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

Review 7.  Proceedings of the fourth international conference on central hypoventilation.

Authors:  Ha Trang; Jean-François Brunet; Hermann Rohrer; Jorge Gallego; Jeanne Amiel; Tiziana Bachetti; Kenneth H Fischbeck; Thomas Similowski; Christian Straus; Isabella Ceccherini; Debra E Weese-Mayer; Matthias Frerick; Katarzyna Bieganowska; Linda Middleton; Francesco Morandi; Giancarlo Ottonello
Journal:  Orphanet J Rare Dis       Date:  2014-12-05       Impact factor: 4.123

8.  Ventilatory and Autonomic Regulation in Sleep Apnea Syndrome: A Potential Protective Role for Erythropoietin?

Authors:  David C Andrade; Liasmine Haine; Camilo Toledo; Hugo S Diaz; Rodrigo A Quintanilla; Noah J Marcus; Rodrigo Iturriaga; Jean-Paul Richalet; Nicolas Voituron; Rodrigo Del Rio
Journal:  Front Physiol       Date:  2018-10-16       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.